These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1863470)

  • 41. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
    J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS.
    Muster T; Guinea R; Trkola A; Purtscher M; Klima A; Steindl F; Palese P; Katinger H
    J Virol; 1994 Jun; 68(6):4031-4. PubMed ID: 7514684
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ; McKenna PM; Arnold BA; Keller PM; Gorny MK; Zolla-Pazner S; Robinson JE; Conley AJ
    AIDS Res Hum Retroviruses; 1997 Dec; 13(18):1549-59. PubMed ID: 9430247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dissection of the humoral immune response toward an immunodominant epitope of HIV: a model for the analysis of antibody diversity in HIV+ individuals.
    Enshell-Seijffers D; Smelyanski L; Vardinon N; Yust I; Gershoni JM
    FASEB J; 2001 Oct; 15(12):2112-20. PubMed ID: 11641237
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro.
    Robinson WE; Gorny MK; Xu JY; Mitchell WM; Zolla-Pazner S
    J Virol; 1991 Aug; 65(8):4169-76. PubMed ID: 2072448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant fusion proteins for haemagglutination-based rapid detection of antibodies to HIV in whole blood.
    Gupta A; Gupta S; Chaudhary VK
    J Immunol Methods; 2001 Oct; 256(1-2):121-40. PubMed ID: 11516760
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates.
    Cotropia J; Ugen KE; Kliks S; Broliden K; Broliden PA; Hoxie JA; Srikantan V; Williams WV; Weiner DB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jul; 12(3):221-32. PubMed ID: 8673526
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of recombinant extended single-chain antibody peptide conjugates for use in the diagnosis of HIV-1 and HIV-2.
    Coia G; Hudson PJ; Lilley GG
    J Immunol Methods; 1996 Jun; 192(1-2):13-23. PubMed ID: 8699008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of a novel human anti-HIV-1 gp41 IgM monoclonal antibody designated clone 37.
    Cao C; Bai Y; Holloway MJ; Edgeworth RL; Jackson EA; Cotropia J; Ugen KE
    DNA Cell Biol; 2004 Dec; 23(12):836-41. PubMed ID: 15684710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds.
    Oakes V; Torralba J; Rujas E; Nieva JL; Domene C; Apellaniz B
    Biochim Biophys Acta Biomembr; 2018 Jun; 1860(6):1259-1271. PubMed ID: 29477358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibody epitopes sensitive to the state of human immunodeficiency virus type 1 gp41 oligomerization map to a putative alpha-helical region.
    Poumbourios P; McPhee DA; Kemp BE
    AIDS Res Hum Retroviruses; 1992 Dec; 8(12):2055-62. PubMed ID: 1283526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The immunodominance of epitopes within the transmembrane protein (gp41) of human immunodeficiency virus type 1 may be determined by the host's previous exposure to similar epitopes on unrelated antigens.
    Davis D; Chaudhri B; Stephens DM; Carne CA; Willers C; Lachmann PJ
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():1975-83. PubMed ID: 2170568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope.
    Menendez A; Chow KC; Pan OC; Scott JK
    J Mol Biol; 2004 Apr; 338(2):311-27. PubMed ID: 15066434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of a soluble and secreted antigenic fragment of HBsAg in yeast.
    Baba EH; Berkower I
    Biochem Biophys Res Commun; 1992 Apr; 184(1):50-9. PubMed ID: 1567451
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein.
    Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro.
    Robinson WE; Kawamura T; Lake D; Masuho Y; Mitchell WM; Hersh EM
    J Virol; 1990 Nov; 64(11):5301-5. PubMed ID: 1698995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop.
    Duarte CA; Montero M; Seralena A; Valdés R; Jiménez V; Benítez J; Narciandi E; Madrazo J; Padrón G; Sánchez G
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):235-43. PubMed ID: 7517147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Binding behaviour of antibodies reacting specifically with an immunodominant region of the transmembrane protein gp41 of HIV-1.
    Döpel SH; Porstmann T; Grunow R; Henklein P; Pas P; von Baehr R
    J Virol Methods; 1990 May; 28(2):189-98. PubMed ID: 1695222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.